HESAI GROUP (HSAI)

US4280501085 - ADR

3.97  -0.03 (-0.75%)

After market: 3.9214 -0.05 (-1.22%)

Fundamental Rating

3

HSAI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 80 industry peers in the Automobile Components industry. While HSAI seems to be doing ok healthwise, there are quite some concerns on its profitability. HSAI shows excellent growth, but is valued quite expensive already.



1

1. Profitability

1.1 Basic Checks

HSAI had negative earnings in the past year.
In the past year HSAI had a positive cash flow from operations.
In the past 5 years HSAI always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: HSAI reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of HSAI (-8.41%) is worse than 87.50% of its industry peers.
HSAI has a worse Return On Equity (-12.32%) than 83.75% of its industry peers.
Industry RankSector Rank
ROA -8.41%
ROE -12.32%
ROIC N/A
ROA(3y)-30%
ROA(5y)-22.46%
ROE(3y)-39.72%
ROE(5y)-29.49%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 35.24%, HSAI belongs to the best of the industry, outperforming 92.50% of the companies in the same industry.
In the last couple of years the Gross Margin of HSAI has declined.
HSAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.06%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

HSAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HSAI remains at a similar level compared to 1 year ago.
Compared to 1 year ago, HSAI has a worse debt to assets ratio.

2.2 Solvency

HSAI has an Altman-Z score of 1.02. This is a bad value and indicates that HSAI is not financially healthy and even has some risk of bankruptcy.
HSAI's Altman-Z score of 1.02 is on the low side compared to the rest of the industry. HSAI is outperformed by 88.75% of its industry peers.
HSAI has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of HSAI (0.08) is better than 88.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 1.02
ROIC/WACCN/A
WACC7.21%

2.3 Liquidity

A Current Ratio of 3.29 indicates that HSAI has no problem at all paying its short term obligations.
HSAI has a better Current ratio (3.29) than 88.75% of its industry peers.
HSAI has a Quick Ratio of 2.92. This indicates that HSAI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.92, HSAI belongs to the best of the industry, outperforming 92.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 2.92

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.89% over the past year.
The Revenue has grown by 56.06% in the past year. This is a very strong growth!
Measured over the past years, HSAI shows a very strong growth in Revenue. The Revenue has been growing by 65.31% on average per year.
EPS 1Y (TTM)35.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.25%
Revenue 1Y (TTM)56.06%
Revenue growth 3Y65.31%
Revenue growth 5YN/A
Sales Q2Q%4.22%

3.2 Future

HSAI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.87% yearly.
HSAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.52% yearly.
EPS Next Y13.41%
EPS Next 2Y43.96%
EPS Next 3Y52.87%
EPS Next 5YN/A
Revenue Next Year17.59%
Revenue Next 2Y31.38%
Revenue Next 3Y32.32%
Revenue Next 5Y27.52%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

HSAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 203.02, which means the current valuation is very expensive for HSAI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HSAI indicates a rather expensive valuation: HSAI more expensive than 85.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.99. HSAI is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 203.02

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HSAI's earnings are expected to grow with 52.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.96%
EPS Next 3Y52.87%

0

5. Dividend

5.1 Amount

HSAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HESAI GROUP

NASDAQ:HSAI (9/18/2024, 8:06:59 PM)

After market: 3.9214 -0.05 (-1.22%)

3.97

-0.03 (-0.75%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap506.09M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 203.02
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.41%
ROE -12.32%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 35.24%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.29
Quick Ratio 2.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)35.89%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y13.41%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)56.06%
Revenue growth 3Y65.31%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y